U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Advancing Regulatory Science
  5. FY25 FDA Broad Agency Announcement Question and Answer Session - 01/16/2025
  1. Advancing Regulatory Science

Webcast | Virtual

Event Title
FY25 FDA Broad Agency Announcement Question and Answer Session
January 16, 2025

Date:
January 16, 2025
Time:
1:00 a.m. - 2:30 p.m. ET
Image
FY25 FDA BAA Question & Answer Session - January 16, 2025

BAA Question and Answers

FY25 FDA Broad Agency Announcement Question and Answer Session

FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. FY25 FDA BAA Question and Answer Session will provide an opportunity to the applicants to learn more about the application process. Join us to learn more about the FY25 BAA application process, next steps, and clarify any questions on how to apply.

Register

Please register in advance to attend this event. Upon registering, you will receive an email including log-in information, and downloadable calendar reminder. There is no cost to attend, and you may cancel your registration at any time. FY25 FDA BAA Question and Answer session will be open to public. This meeting will be recorded and recording of the full event (including closed captioning and an audio transcript), presentation slides, responses to polls, and answers to all questions (received via email to FDABAA mailbox and live) will be posted.

Intended audience

The FDA BAA is open to all responsible sources, and small businesses are strongly encouraged to respond. Offerors may include single entities or teams from private sector organizations, Federally Funded Research and Development Centers (FFRDCs), and/or academic institutions, recipients of early concept paper recommendations (submit or do not submit), potential FY25 applicants.

Agenda and speaker information

Agenda and Speaker bios are available under Event Materials at the bottom of this page.

Agenda

All times are Eastern Standard Time.

Time Agenda item Presenter
1:00 p.m.

Submission Etiquette and Communication

# Template Dos and Don'ts

# Required documents

 

Dr. Kinnera Chada, ORES

Mr. Ian Weiss, OAGS
1:20 p.m.

# Question and Answer Panel

# Review of questions submitted via webinar Q&A pod, and in advance to FDABAA@fda.hhs.gov

Panel Members: ORES & OAGS
2:25 p.m. Adjourn and Closing Remarks

Note: Recording of the full event (including closed captioning and an audio transcript), presentation slides, responses to polls, and answers to all questions (received via email to FDABAA mailbox and live) will be posted below.

Fiscal Year 2025 (FY25) BAA solicitation

FDA solicits for advanced research and development proposals to support regulatory science and innovation. FDA anticipates that research and development activities awarded under this BAA will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation. View the FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science on SAM.gov.

Contact us / submit a question

Questions may be submitted in advance. Please contact FDABAA@fda.hhs.gov with questions, including any questions you would like us to answer at this event.

Information for Previous event

2024 FDA Broad Agency Announcement Day

2023 FDA Broad Agency Announcement Day

 

Event Materials

Title File Type/Size
FY25 FDA BAA QA Bios Book pdf (397.54 KB)
FY25 FDA BAA QA Agenda.pdf pdf (232.88 KB)
Back to Top